Compare LYV & A Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LYV | A |
|---|---|---|
| Founded | 2005 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.5B | 39.8B |
| IPO Year | N/A | 1999 |
| Metric | LYV | A |
|---|---|---|
| Price | $142.92 | $136.63 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 21 | 15 |
| Target Price | ★ $175.38 | $162.80 |
| AVG Volume (30 Days) | ★ 2.8M | 2.0M |
| Earning Date | 02-19-2026 | 11-24-2025 |
| Dividend Yield | N/A | ★ 0.75% |
| EPS Growth | ★ 59.87 | 3.16 |
| EPS | 1.38 | ★ 4.57 |
| Revenue | ★ $24,569,494,000.00 | $6,948,000,000.00 |
| Revenue This Year | $9.27 | $8.00 |
| Revenue Next Year | $9.36 | $6.29 |
| P/E Ratio | $103.42 | ★ $29.77 |
| Revenue Growth | 5.48 | ★ 6.73 |
| 52 Week Low | $112.88 | $96.43 |
| 52 Week High | $175.25 | $160.27 |
| Indicator | LYV | A |
|---|---|---|
| Relative Strength Index (RSI) | 54.25 | 36.20 |
| Support Level | $135.05 | $136.23 |
| Resistance Level | $146.60 | $139.07 |
| Average True Range (ATR) | 2.73 | 2.03 |
| MACD | 0.66 | -0.23 |
| Stochastic Oscillator | 67.97 | 2.74 |
Live Nation is the largest live entertainment company in the world, serving as a concert promoter, venue operator, and ticketing platform. In addition, the firm generates revenue from sponsorships and advertising. With offices in 45 countries, Live Nation promotes concerts globally and it owned, operated, or had exclusive booking rights to nearly 400 venues worldwide at the end of 2024, which the firm says makes it the second-largest operator of music venues globally. In 2024, Live Nation promoted nearly 55,000 events, drawing more than 150 million fans. Ticketmaster is a dominant global ticketing service, selling almost 640 million tickets in 2024.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.